Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Current In Vivo Models of Varicella-Zoster Virus Neurotropism.

Mahalingam R, Gershon A, Gershon M, Cohen JI, Arvin A, Zerboni L, Zhu H, Gray W, Messaoudi I, Traina-Dorge V.

Viruses. 2019 May 31;11(6). pii: E502. doi: 10.3390/v11060502. Review.

2.

The C-terminus of varicella-zoster virus glycoprotein M contains trafficking motifs that mediate skin virulence in the SCID-human model of VZV pathogenesis.

Zerboni L, Sung P, Sommer M, Arvin A.

Virology. 2018 Oct;523:110-120. doi: 10.1016/j.virol.2018.08.003. Epub 2018 Aug 14.

PMID:
30119012
3.

Age-Associated Differences in Infection of Human Skin in the SCID Mouse Model of Varicella-Zoster Virus Pathogenesis.

Zerboni L, Sung P, Lee G, Arvin A.

J Virol. 2018 May 14;92(11). pii: e00002-18. doi: 10.1128/JVI.00002-18. Print 2018 Jun 1.

4.

Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo.

Zerboni L, Arvin A.

PLoS Pathog. 2015 Jun 19;11(6):e1004989. doi: 10.1371/journal.ppat.1004989. eCollection 2015 Jun.

5.

Autophagic flux without a block differentiates varicella-zoster virus infection from herpes simplex virus infection.

Buckingham EM, Carpenter JE, Jackson W, Zerboni L, Arvin AM, Grose C.

Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):256-61. doi: 10.1073/pnas.1417878112. Epub 2014 Dec 22.

6.

Molecular mechanisms of varicella zoster virus pathogenesis.

Zerboni L, Sen N, Oliver SL, Arvin AM.

Nat Rev Microbiol. 2014 Mar;12(3):197-210. doi: 10.1038/nrmicro3215. Epub 2014 Feb 10. Review.

7.

Identification of a hydrophobic domain in varicella-zoster virus ORF61 necessary for ORF61 self-interaction, viral replication, and skin pathogenesis.

Wang L, Rajamani J, Sommer M, Zerboni L, Arvin AM.

J Virol. 2013 Apr;87(7):4075-9. doi: 10.1128/JVI.02963-12. Epub 2013 Jan 23.

8.

Herpes simplex virus 1 tropism for human sensory ganglion neurons in the severe combined immunodeficiency mouse model of neuropathogenesis.

Zerboni L, Che X, Reichelt M, Qiao Y, Gu H, Arvin A.

J Virol. 2013 Mar;87(5):2791-802. doi: 10.1128/JVI.01375-12. Epub 2012 Dec 26.

9.

Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis.

Sen N, Che X, Rajamani J, Zerboni L, Sung P, Ptacek J, Arvin AM.

Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):600-5. doi: 10.1073/pnas.1114232109. Epub 2011 Dec 21.

10.

Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts.

Zerboni L, Arvin A.

J Neurovirol. 2011 Dec;17(6):570-7. doi: 10.1007/s13365-011-0066-x. Epub 2011 Dec 8. Review.

PMID:
22161683
11.

Apparent expression of varicella-zoster virus proteins in latency resulting from reactivity of murine and rabbit antibodies with human blood group a determinants in sensory neurons.

Zerboni L, Sobel RA, Lai M, Triglia R, Steain M, Abendroth A, Arvin A.

J Virol. 2012 Jan;86(1):578-83. doi: 10.1128/JVI.05950-11. Epub 2011 Oct 19.

12.

VZV: pathogenesis and the disease consequences of primary infection.

Moffat J, Ku CC, Zerboni L, Sommer M, Arvin A.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 37.

13.

Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.

Reichelt M, Wang L, Sommer M, Perrino J, Nour AM, Sen N, Baiker A, Zerboni L, Arvin AM.

PLoS Pathog. 2011 Feb 3;7(2):e1001266. doi: 10.1371/journal.ppat.1001266.

14.

Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis.

Zerboni L, Berarducci B, Rajamani J, Jones CD, Zehnder JL, Arvin A.

J Virol. 2011 Jan;85(1):98-111. doi: 10.1128/JVI.01902-10. Epub 2010 Oct 20.

15.

Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.

Arvin AM, Moffat JF, Sommer M, Oliver S, Che X, Vleck S, Zerboni L, Ku CC.

Curr Top Microbiol Immunol. 2010;342:189-209. doi: 10.1007/82_2010_29. Review.

16.

Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts.

Zerboni L, Reichelt M, Arvin A.

Curr Top Microbiol Immunol. 2010;342:255-76. doi: 10.1007/82_2009_8. Review.

PMID:
20225014
17.

Analysis of the functions of glycoproteins E and I and their promoters during VZV replication in vitro and in skin and T-cell xenografts in the SCID mouse model of VZV pathogenesis.

Arvin AM, Oliver S, Reichelt M, Moffat JF, Sommer M, Zerboni L, Berarducci B.

Curr Top Microbiol Immunol. 2010;342:129-46. doi: 10.1007/82_2009_1. Review.

PMID:
20186616
18.

Expression of varicella-zoster virus immediate-early regulatory protein IE63 in neurons of latently infected human sensory ganglia.

Zerboni L, Sobel RA, Ramachandran V, Rajamani J, Ruyechan W, Abendroth A, Arvin A.

J Virol. 2010 Apr;84(7):3421-30. doi: 10.1128/JVI.02416-09. Epub 2010 Jan 27.

19.

Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.

Berarducci B, Rajamani J, Zerboni L, Che X, Sommer M, Arvin AM.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):282-7. doi: 10.1073/pnas.0912373107. Epub 2009 Dec 4.

20.

Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model.

Vleck SE, Oliver SL, Reichelt M, Rajamani J, Zerboni L, Jones C, Zehnder J, Grose C, Arvin AM.

J Virol. 2010 Jan;84(1):141-52. doi: 10.1128/JVI.01338-09.

21.

Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo.

Oliver SL, Sommer M, Zerboni L, Rajamani J, Grose C, Arvin AM.

J Virol. 2009 Aug;83(15):7495-506. doi: 10.1128/JVI.00400-09. Epub 2009 May 27.

22.

Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.

Berarducci B, Rajamani J, Reichelt M, Sommer M, Zerboni L, Arvin AM.

J Virol. 2009 Jan;83(1):228-40. doi: 10.1128/JVI.00913-08. Epub 2008 Oct 22.

23.

Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts.

Oliver SL, Zerboni L, Sommer M, Rajamani J, Arvin AM.

J Virol Methods. 2008 Dec;154(1-2):182-93. doi: 10.1016/j.jviromet.2008.07.033. Epub 2008 Sep 24.

24.

Functions of Varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection.

Chaudhuri V, Sommer M, Rajamani J, Zerboni L, Arvin AM.

J Virol. 2008 Oct;82(20):10231-46. doi: 10.1128/JVI.01890-07. Epub 2008 Aug 6.

25.

Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection.

Che X, Reichelt M, Sommer MH, Rajamani J, Zerboni L, Arvin AM.

J Virol. 2008 Jun;82(12):5825-34. doi: 10.1128/JVI.00303-08. Epub 2008 Apr 9.

26.

Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia.

Reichelt M, Zerboni L, Arvin AM.

J Virol. 2008 Apr;82(8):3971-83. doi: 10.1128/JVI.02592-07. Epub 2008 Feb 6.

27.

Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I.

Zerboni L, Reichelt M, Jones CD, Zehnder JL, Ito H, Arvin AM.

Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14086-91. Epub 2007 Aug 20.

28.

Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication.

Berarducci B, Sommer M, Zerboni L, Rajamani J, Arvin AM.

J Virol. 2007 Oct;81(19):10258-67. Epub 2007 Jul 18.

29.

ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo.

Schaap-Nutt A, Sommer M, Che X, Zerboni L, Arvin AM.

J Virol. 2006 Dec;80(23):11806-16. Epub 2006 Sep 13.

30.
31.

T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection.

Schaap A, Fortin JF, Sommer M, Zerboni L, Stamatis S, Ku CC, Nolan GP, Arvin AM.

J Virol. 2005 Oct;79(20):12921-33.

32.

Varicella-zoster virus infection of human dorsal root ganglia in vivo.

Zerboni L, Ku CC, Jones CD, Zehnder JL, Arvin AM.

Proc Natl Acad Sci U S A. 2005 May 3;102(18):6490-5. Epub 2005 Apr 25.

33.

Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo.

Ito H, Sommer MH, Zerboni L, Baiker A, Sato B, Liang R, Hay J, Ruyechan W, Arvin AM.

J Virol. 2005 Apr;79(8):4819-27.

34.

Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.

Zerboni L, Hinchliffe S, Sommer MH, Ito H, Besser J, Stamatis S, Cheng J, Distefano D, Kraiouchkine N, Shaw A, Arvin AM.

Virology. 2005 Feb 5;332(1):337-46.

35.

Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells.

Besser J, Ikoma M, Fabel K, Sommer MH, Zerboni L, Grose C, Arvin AM.

J Virol. 2004 Dec;78(23):13293-305.

36.

Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo.

Moffat J, Mo C, Cheng JJ, Sommer M, Zerboni L, Stamatis S, Arvin AM.

J Virol. 2004 Nov;78(22):12406-15.

37.

Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha.

Ku CC, Zerboni L, Ito H, Graham BS, Wallace M, Arvin AM.

J Exp Med. 2004 Oct 4;200(7):917-25. Epub 2004 Sep 27.

38.

Varicella-zoster virus infection of human neural cells in vivo.

Baiker A, Fabel K, Cozzio A, Zerboni L, Fabel K, Sommer M, Uchida N, He D, Weissman I, Arvin AM.

Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10792-7. Epub 2004 Jul 9.

39.
41.
43.
44.

Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus.

Sommer MH, Zagha E, Serrano OK, Ku CC, Zerboni L, Baiker A, Santos R, Spengler M, Lynch J, Grose C, Ruyechan W, Hay J, Arvin AM.

J Virol. 2001 Sep;75(17):8224-39.

45.

Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells.

Hata A, Zerboni L, Sommer M, Kaspar AA, Clayberger C, Krensky AM, Arvin AM.

Viral Immunol. 2001;14(2):125-33.

PMID:
11398808
46.

Varicella-zoster virus infection of a human CD4-positive T-cell line.

Zerboni L, Sommer M, Ware CF, Arvin AM.

Virology. 2000 May 10;270(2):278-85.

47.

The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse.

Moffat JF, Zerboni L, Sommer MH, Heineman TC, Cohen JI, Kaneshima H, Arvin AM.

Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11969-74.

48.

Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine.

Zerboni L, Nader S, Aoki K, Arvin AM.

J Infect Dis. 1998 Jun;177(6):1701-4.

PMID:
9607852
49.
50.

Reliability of a history of previous varicella infection in adults.

Wallace MR, Chamberlin CJ, Zerboni L, Sawyer MH, Oldfield EC, Olson PE, Arvin AM.

JAMA. 1997 Nov 12;278(18):1520-2.

PMID:
9363973

Supplemental Content

Loading ...
Support Center